The P/B of 4.07 is near the peer median, yet the trailing P/E of 23.45 sits above Lazard and Moelis, which may indicate the market is capitalizing a counter-cyclical restructuring franchise. Because the book value is largely intangible-light and the tangible book per share has risen from $6.65 to $12.53 over ten quarters, the valuation appears increasingly anchored to earnings power rather than balance sheet claims. Investors should monitor whether the 3.63 PEG, which looks elevated, reflects expectations for sustained margin recovery that the reported EPS miss has not yet confirmed.

The gap between ROE and ROA reflects the very low leverage in the structure, so returns depend on operating margin and fee productivity rather than balance sheet gearing. The most recent quarter's 4.6% ROE, below the 5.7% peak, suggests the EPS miss translated into weaker earnings per dollar of capital. Relative to peers such as Moelis at 35.6% ROE, HLI's returns appear structurally lower, which may reflect a more conservative capital posture rather than an operating deficiency.

A high equity ratio of this magnitude indicates the firm is not relying on balance sheet leverage to generate returns, which lowers insolvency risk even when deal flow weakens. The swings in liabilities between $1.1B and $1.9B appear to track the timing of receivables and restructuring-related obligations rather than structural borrowing. Investors should watch whether the cushion is maintained as cash deployment into acquisitions and buybacks accelerates.